Should You Take Soma and Cyclobenzaprine Together?
No, you should not take carisoprodol (Soma) and cyclobenzaprine together. This combination significantly increases the risk of excessive central nervous system (CNS) depression, leading to dangerous sedation, respiratory depression, and other serious adverse effects.
Why This Combination Is Dangerous
Both carisoprodol and cyclobenzaprine are centrally acting muscle relaxants that depress the CNS through different but overlapping mechanisms 1. When combined, their sedative effects are additive, creating a substantially higher risk profile than either drug alone.
Key Safety Concerns
Carisoprodol (Soma) has particularly concerning characteristics:
- It acts as a CNS depressant with barbiturate-like biological action 1
- Classified as a controlled substance due to abuse and addiction potential 1
- Causes sedation, seizures, drug dependence, tachycardia, and postural hypotension 1
- The FDA reports escalating abuse in the past decade, making it one of the most commonly diverted drugs 1
Cyclobenzaprine carries its own risks:
- Structurally related to tricyclic antidepressants (amitriptyline) 1
- Causes anticholinergic effects including hallucinations, confusion, drowsiness, constipation, and urinary retention 1
- Can interact with sedatives and anesthetic agents 1
- The FDA label explicitly warns that cyclobenzaprine "may enhance the effects of alcohol, barbiturates, and other CNS depressants" 2
Evidence of Harm from Combining Muscle Relaxants
Research demonstrates that combining muscle relaxants with other CNS depressants increases injury risk. A large case-control study of 27,974 older adults found that skeletal muscle relaxant use was associated with a 32% increased risk of injury (OR 1.32,95% CI 1.16-1.50) 3. Specifically:
- Carisoprodol: 73% increased injury risk (OR 1.73) 3
- Cyclobenzaprine: 22% increased injury risk (OR 1.22) 3
While this study examined individual agents, the additive CNS depression from combining two muscle relaxants would logically amplify these risks substantially.
Clinical Recommendations
If you are currently taking both medications:
- Contact your prescribing physician immediately
- Do not stop either medication abruptly, especially carisoprodol, which requires slow tapering over 4-9 days to prevent severe withdrawal symptoms 1
Alternative approaches:
- Use only one muscle relaxant at a time
- Consider switching from carisoprodol to a safer alternative given its abuse potential and FDA concerns 1
- Cyclobenzaprine has the most robust clinical trial evidence for efficacy in musculoskeletal conditions 4, 5
Special Populations at Higher Risk
Older adults (≥65 years):
- The 2019 American Geriatrics Society Beers Criteria recommends avoiding both carisoprodol and cyclobenzaprine in older adults 6
- Cyclobenzaprine plasma concentrations are approximately 1.7-fold higher in elderly patients 2
- If cyclobenzaprine must be used in elderly patients, start with 5 mg and titrate slowly 2
Patients with hepatic impairment:
- Cyclobenzaprine levels approximately double in hepatic impairment 2
- Both medications should be avoided or used with extreme caution 1, 2
Common Pitfalls to Avoid
- Never combine multiple CNS depressants without explicit physician guidance, including alcohol, benzodiazepines, or opioids with these muscle relaxants
- Do not assume "natural" alternatives are safer - the combination of two prescription muscle relaxants is inherently high-risk
- Avoid driving or operating machinery if taking either medication, and absolutely avoid these activities if somehow taking both
- Watch for signs of excessive sedation: extreme drowsiness, confusion, difficulty breathing, or inability to stay awake - these are medical emergencies
The bottom line: Choose one muscle relaxant, preferably cyclobenzaprine based on evidence, and avoid combining them. If pain control is inadequate with a single agent, discuss alternative pain management strategies with your physician rather than adding another CNS depressant.